Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesobotox plus intradermal triamcinolone for alopecia areata
IRCT20260516069415N1Phase 3Recruiting
- Sponsor
- Iran University of Medical Sciences
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of neuronox and triamcinolone in alopecia areata, sponsored by Iran University of Medical Sciences. Started Aug 2026; status: recruiting.
02
Drugs
neuronoxtriamcinolone
03
Conditions
alopecia areata
Beyond the preview
Go deeper on IRCT20260516069415N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260516069415N1.